Tolerance to the antinociceptive effect of epibatidine after acute and chronic administration in mice

European Journal of Pharmacology

Volumn 300, Issue 1-2, 1996, Pages 51-57

  Damaj, M Imad ^a   Martin, Billy R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antinociception; Epibatidine; Mouse; Nicotine; Tolerance

Indexed keywords

ANALGESIC AGENT; EPIBATIDINE; NICOTINE; RADIOLIGAND;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BRAIN; CONTROLLED STUDY; CROSS TOLERANCE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG RECEPTOR BINDING; DRUG TOLERANCE; ENANTIOMER; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL FLICK TEST;

EID: 0013656413     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00834-9     Document Type: Article

References (38)

1. Aceto, M.D., B.R. Martin, LM. Uwaydah, E.L. May, L.S. Harris, C. Izazola-Conde, W.L. Dewey and W.C. Vincek, 1919, Optically pure (+)-nicotine from (±)-nicotine and biological comparisons with (-)-nicotine, J. Med. Chem. 22, 174.
2. Badio, B. and J. Daly, 1994, Epibatidine, a potent analgetic and nicotinic agonist, Mol. Pharmacol. 45, 563.
3. Balfour, D.J.K. and M.E.M. Benwell, 1981, Effects of chronic nicotine administration on plasma corticosterone and brain 5-hydroxyindoles in stressed rats, Br. J. Pharmacol. 1-3, 212.
4. Benowitz, N.L., 1992, Cigarette smoking and nicotine addiction, Med. Clin. N. Am. 76, 415.
5. Benwell, M., D. Balfour and C. Birell, 1995, Desensitization of the nicotine-induced mesolimbic dopamine responses during constant infusion with nicotine, Br. J. Pharmacol. 114, 454.
6. Bhat, R.V., S.L. Turner, S.R. Selvaag, M.J. Marks and A.C. Collins, 1991. Regulation of brain nicotinic receptors by chronic agonist infusion, J. Neurochem, 56, 1932.
7. D'Amour, F.E. and D.L. Smith, 1941, A method for determining loss of pain sensation, J. Pharmacol. Exp. Ther. 72, 74.
8. Damaj, M.I., K.R. Creasy, A.D. Grove, J.A. Rosecrans and B.R. Martin, 1994a, Pharmacological effects of epibatidine optical enantiomers, Brain Res. 664, 34.
9. Damaj, M.I., S. Tucker, M. Aceto and B.R. Martin, 1994b, Analgesic activity of epibatidine and its enantiomers in a chemical model of pain in mice, Med. Chem. Res. 4, 483.
10. Dewey, W.L., L.S. Harris, J.S. Howes and J.A. Nuite, 1970, The effect of various neurohormonal modulations on the activity of morphine and the narcotic antagonists in taik-flick and phenylquinone test, J. Pharmacol. Exp. Ther. 175, 435.
11. Dunlop, C.W., C. Stumpf, D.S. Maxwell and W. Schindler, 1960, Modification of cortical, reticular and hippocampal unit activity by nicotine in the rabbit, Am. J. Physiol. 198, 515.
12. Flores, C.M., S.W. Rogers, L.A. Pabreza, B.B. Wolfe and K.J. Kellar, 1992. A subtype of nicotinic cholinergic receptor in the rat brain is composed of alpha-4 and beta-2 subunits and is up-regulated by chronic nicotine treatment, Mol. Pharmacol. 41, 31.
13. Grun, E.A., J.R. Pauly and A.C. Collins, 1992, Adrenalectomy reverses chronic injection-induced tolerance to nicotine, Psychopharmacology 109, 299.
14. Grunberg, N.E., D.J. Bowen and D.E. Morse, 1984, Effects of nicotine on body weight and food consumption in rats, Psychopharmacology 83, 93.
15. Hulihan-Giblin, B.A., M.D. Lumpkin and K.J. Kellar, 1990a, Acute effects of nicotine on prolactin release in the rat: agonist and antagonist effects of a single injection of nicotine, J. Pharmacol. Exp. Ther. 252, 15.
16. Hulihan-Giblin, B.A., M.D. Lumpkin and KJ. Kellar, 1990b, Effects of chronic administration of nicotine on prolactin release in the rat: inactivation of prolactin response by repeated injections of nicotine, J. Pharmacol. Exp. Ther. 252, 21.
17. Loring, R.H., T. McHugh, J. McKay and X.G. Zhang, 1994, Epibatidine: a potent desensitizing agonist of neuronal nicotinic receptors in the chick nernous system, Med. Chem. Res. 4, 517.
18. Marks, M.J. and A.C. Collins, 1985, Tolerance, cross-tolerance, and receptors after chronic nicotine or oxotremorine, Pharmacol. Biochem. Behav. 22, 283.
19. Marks, M.J., S.M. Campbell, E. Romm and A.C. Collins, 1991, Genotype influences the development of tolerance to nicotine in the mouse, J. Pharmacol. Exp. Ther. 259, 392.
20. Marks, M., S. Grady and A. Collins, 1993, Down-regulation of nicotinic receptor function after chronic nicotine infusion, J. Pharmacol. Exp. Ther. 266, 1268.
21. + efflux from mouse brain synaptosomes, J. Neurochem. 63, 2125.
22. Matta, S.G., C.A. Foster and B.M. Sharp, 1993, Nicotine stimulates the expression of cFos protein in the parvocellular paraventricular nucleus and brainstem catecholaminergic regions, Endocrinology 132, 2149.
23. Miner, L.L. and A.C. Collins, 1988, Effect of nicotine pretreatment on nicotine-induced seizures, Pharmacol. Biochem. Behav. 29, 375.
24. Ochoa, E.L.M., L. Li and M.G. McNamee, 1990, Desensitization of central cholinergic mechanisms and neuroadaption to nicotine, Mol. Neurobiol. 4, 251.
25. Pauly, J.R., E.U. Grun and A.C. Collins, 1990, Chronic corticosterone administration modulates nicotine sensitivity and brain nicotinic receptor binding in C3H mice, Psychopharmacology 101, 310.
26. Pauly, J.R., E.U. Grun and A.C. Collins, 1992, Tolerance to nicotine following chronic treatment by injections: A potential role for corticosterone, Psychopharmacology 108, 33.
27. Qian, C., T. Li, T. Shen, L. Libertine-Graham, J. Eckman, T. Biftu and S. Ip, 1993, Epibatidine is a nicotinic analgesic, Eur. J. Pharmacol. 250, R13.
28. Qian, C., S. Chen, L. Libertine-Graham, D.M. Wypij, P. Yao, F. Zuo and J. Eckman, 1994, Effects of epibatidine on body weight in mice, Med. Chem. Res. 4, 493.
29. 3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs, J. Neurochem, 45, 427.
30. 3H]nicotine binding to mouse brain homogenate, J. Pharm. Pharmacol. 40, 793.
31. Sharp, B.M. and H.S. Beyer, 1986, Rapid desensitization of the acute stimulatory effects of nicotine on rat plasma adrenocorticotropin and prolactin, J. Pharmacol. Exp. Ther. 238, 486.
32. Spande, T., H. Garraffo, M. Edwards, H. Yeh, L. Pannell and J. Daly, 1992, Epibatidine: a novel (chloropyridyl) azabicycloheptane with potent anigesic activity from an ecuadoran poison frog, J. Am. Chem. Soc. 114, 3475.
33. Stolerman, I.P., R. Fink and M.E. Jarvik, 1973, Acute and chronic tolerance to nicotine measured by activity in rats, Psychopharmacology 30, 329.
34. Sullivan, J.P., M.W. Decker, J. Brioni, D. Donnelly-Roberts, D.J. Anderson, A.W. Bannon, C. Kang, P. Adams, M. Piattoni-Kaplan, M. Buckley, M. Gopalakrishnan, M. Williams and S.P. Arneric, 1994, (±)Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors, J. Pharmacol. Exp. Ther. 271, 624.
35. Surgeon, G., 1988, The Health Consequences of Smoking: Nicotine Addiction. A Report of the Surgeon General (U.S. Gov. Printing Office, Washington, D.C.).
36. Tallanda, R.J. and R.B. Murray, 1987, Manual of Pharmacological Calculations with Computer Programs (Springer-Verlag, New York) p. 293.
37. Wonnacott, S., 1990, The paradox of nicotinic acetylcholine receptor upregulation, Trends Pharmacol. Sci. 11, 216.
38. Yang, X. and J. Buccafusco, 1994, Effect of chronic central treatment with the acetylcholine analog methylcarbamylcholine on cortical nicotinic receptors: correlation between receptor changes and behavioral function, J. Pharmacol. Exp. Ther. 271, 651.